| COLL Stock Yearly Return 2023 Table | ||||||||||||||||||||||||||||||
COLL average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare COLL average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| COLL Share Performance |
| COLL Stock Yearly Return 2023 Chart | |||
Also see: • COLL YTD return • COLL average annual return 10 years | |||
| About Collegium Pharmaceutical Inc |
| Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic. The COLL stock yearly return is shown above.
The yearly return on the COLL stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2023 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the COLL annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| COLL Current Stock Quote |
 Free COLL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Collegium Pharmaceutical (COLL) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
COM Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.
Video: Don't Forget Dividends in Average Annual Return!